|
C1ORF96 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.193600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.780000E-01 |
| Normal-vs-Stage2 |
6.822000E-01 |
| Normal-vs-Stage3 |
7.672000E-02 |
| Normal-vs-Stage4 |
2.751600E-02 |
| Stage1-vs-Stage2 |
2.504200E-01 |
| Stage1-vs-Stage3 |
3.707400E-01 |
| Stage1-vs-Stage4 |
8.135700E-02 |
| Stage2-vs-Stage3 |
6.740000E-02 |
| Stage2-vs-Stage4 |
2.345800E-02 |
| Stage3-vs-Stage4 |
2.889800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.323700E-02 |
| Normal-vs-AfricanAmerican |
1.262380E-01 |
| Normal-vs-Asian |
5.251000E-01 |
| Caucasian-vs-AfricanAmerican |
3.440400E-01 |
| Caucasian-vs-Asian |
5.261200E-01 |
| AfricanAmerican-vs-Asian |
2.363200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.926000E-01 |
| Normal-vs-Female |
1.122450E-01 |
| Male-vs-Female |
7.333400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.071000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.274400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.144500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.251200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.311400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.586970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.421200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.243000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.963400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.113200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.415600E-01 |
| Classical-VS-Follicular |
3.56747964502802E-12 |
| Classical-VS-Other |
1.433040E-01 |
| Classical-VS-Normal |
2.016100E-03 |
| Tall-VS-Follicular |
1.95653999999212E-05 |
| Tall-VS-Other |
1.036360E-01 |
| Tall-VS-Normal |
5.106200E-02 |
| Follicular-VS-Other |
4.961000E-01 |
| Follicular-VS-Normal |
2.555100E-03 |
| Other-VS-Normal |
4.503600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.779800E-01 |
| Normal-vs-N1 |
5.769000E-01 |
| N0-vs-N1 |
3.890600E-01 |
|
|
